This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (2) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cook, P. F. Articles by McCabe, M. M. Search for Related Content PubMed PubMed Citation Articles by Cook, P. F. Articles by McCabe, M. M. Pubmed/NCBI databases Medline Plus Health Information Osteoporosis Social Bookmarking                         What's this?

Telephone Counseling to Improve Osteoporosis Treatment Adherence: An Effectiveness Study in Community Practice Settings

University of Colorado at Denver and Health Sciences Center, paul.cook{at}uchsc.edu

Suzie Emiliozzi, RN

ScriptAssist Medication Compliance Programs

Mishcha M. McCabe, RN, DNP

University of Colorado at Denver and Health Sciences Center

Treatment nonadherence is a recognized problem, but most practice settings use education alone to address it. Psychological counseling methods generate greater behavior change but are not widely used. Telehealth nursing can be used to integrate these methods into routine clinical practice. This study was a nonrandomized trial of a telehealth program that used motivational interviewing and cognitive— behavioral techniques to improve osteoporosis medication adherence. Registered nurses delivered the intervention to 402 participants recruited from provider offices across the United States. Initial participation rates were high in this community-based sample, although attrition also was high. Six-month adherence based on pharmacy and clinical interview data was significantly higher than the general population rate. A comparison with nonparticipants approached significance, and there was a significant dose—response effect. Most reasons given for nonadherence were psychological. The results support the use of psychological techniques to improve adherence and the use of telehealth to disseminate evidence-based patient counseling. (Am J Med Qual 2007;22 445-456)

Key Words: compliance • adherence • osteoporosis • telehealth • motivational interviewing

References

• Cummings N. Psychological approaches to disease management. Panel discussion at: Conference on Psychological Approaches to Disease Management; May 21, 2004; Reno, NV.
• Smith P., Andrews J. Drug compliance not so bad, knowledge not so good: the elderly after hospital discharge. Age Ageing. 1993;12:336-342.[CrossRef]
• Cook PF Psychosocial interventions to improve medication compliance: a meta-analysis. http://www.scriptassistllc.com/vendor/research. Accessed June 8, 2006.
• McDonald HP, Garg AX, Haynes RB Interventions to enhance patient adherence to medication prescriptions. JAMA. 2002; 288:2868-2879.[Abstract/Free Full Text]
• Mullen PD, Green LW, Persinger GS Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types. Prev Med. 1985;14:753-781.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cook PF Adherence to medications. In: O'Donohue WT, Levensky ER, eds. Promoting Treatment Adherence: A Practical Handbook for Health Care Providers. Thousand Oaks, CA: Sage; 2006:183-202.
• Burke BL, Arkowitz H., Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843-861.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Compas BE, Keefe FJ, Haaga Daf, Leitenberg H., Williams DA Sampling of empirically supported psychological treatments from health psychology: smoking, chronic pain, cancer and bulimia nervosa. J Consult Clin Psychol. 1998;66:89-112.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rollnick S., Mason P., Butler C. Health Behavior Change: A Guide for Practitioners. New York, NY: Churchill Livingstone; 1999.
• Dolcini MM, Canin L., Gandelman A., Skolnik H. Theoretical domains: a heuristic for teaching behavioral theory in HIV/STD prevention courses. Health Promot Pract. 2004; 5:404-417.[Abstract/Free Full Text]
• Prochaska JO, Prochaska JM Why don't continents move? Why don't people change? J Psychother Integration. 1999; 9:102.
• Frosch DL, Kaplan RM Shared decision making in clinical medicine: past research and future directions. Am J Prev Med. 1999;17:285-294.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Miller WR, Rollnick S. Motivational Interviewing. New York, NY: Guilford Press; 1992.
• Meichenbaum DC, Turk D. Facilitating Treatment Adherence: A Practitioner's Guidebook. New York, NY: Plenum Press; 1987.
• World Health Organization. Prevention and management of osteoporosis. http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf. Accessed June 15, 2006.
• Alendronate (Fosamax) and risedronate (Actonel) revisited. Obstet Gynecol. 2005;106:402-403.[Medline] [Order article via Infotrieve]
• National Osteoporosis Foundation. Prevention: who's at risk? http://www.nof.org/prevention/risk.htm. Accessed August 24, 2007.
• Lippuner K., von Overbeck J., Perrelet R., Bosshard H., Jaeger P. Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporos Int. 1997;7:414-425.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ray NF, Chan JK, Thamer M., Melton LJ Iii. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:24-35.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lippuner K., Golder M., Greiner R. Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int. 2004;16(suppl 2):S8-S17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• National Committee for Quality Assurance. The State of Health Care Quality 2006. http://web.ncqa.org/tabid/447/Default.aspx. Accessed August 24, 2007.
• Centers for Medicare & Medicaid Services. Physician quality reporting initiative. http://www.cms.hhs.gov/PQRI/. Accessed March 7, 2007.
• Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and aledronate (REAL) cohort study. Osteoporos Int. 2007;18:25-34.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• National Council on Patient Information and Education. Prescription Medication Compliance: A Review of the Baseline of Knowledge. Washington, DC: National Council on Patient Information and Education; 1995.
• Miller PD Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy. Clin Ther. 2005;27:361-376.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chapman GB Short-term cost for long-term benefit: time preference and cancer control. Health Psychol. 2005;24(suppl): S41-S48.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Orbell S., Hagger M. Temporal framing and the decision to take part in Type 2 diabetes screening: effects of individual differences in consideration of future consequences on persuasion. Health Psychol. 2006;25:537-548.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Beck J. Improving medication compliance with cognitive techniques. Open Minds Advisor. 2000;August:1-3.
• Levy RA Failure to refill prescriptions: incidence, reasons and remedies. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York, NY: Raven Press; 1991:11-18.
• National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. http://www.guideline.gov/summary/summary.aspx?doc_id=3862. Accessed August 15, 2006.
• Clemmesen B., Ravn P., Zegels B., Taquet AN, Christiansen C., Reginster JY A 2-year phase II study with 1 year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis. Osteoporos Int. 1997;7:488-495.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA. 1999;282:1344-1352.[Abstract/Free Full Text]
• Lanza FL, Rack MF, Li Z., Krajewski SA, Blank MA Placebo-controlled, randomized, evaluator-blinded endoscopy study of risedronate vs. aspirin in healthy postmenopausal women. Aliment Pharmacol Ther. 2002;14:1663-1670.
• McClung M., Geusens P., Miller P., et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med. 2001;344:333-340.[Abstract/Free Full Text]
• Mortensen L., Charles P., Bekker PJ, Digennaro J., Johnston CC Jr. Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab. 1998;83:396-402.[Abstract/Free Full Text]
• Wysowski DK, Chang JT Alendronate and risedronate: reports of severe bone, joint, and muscle pain. Arch Intern Med. 2005;165:364-365.
• Leite AF, Figueiredo PT, Melo NS, et al. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:14-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cargill JM Medication compliance in elderly people: influencing variables and interventions. J Adv Nurs. 1992;17: 422-426.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Amaral PL The special case of compliance in the elderly. In: Gerber KE, Nehemkis AM, eds. Compliance: The Dilemma of the Chronically Ill. New York, NY: Springer; 1986:128-157.
• Salzman C. Medication compliance in the elderly. J Clin Psychol. 1995;56(suppl 1):18-22.
• Book HE Some psychodynamics of non-compliance. Can J Psychiatry. 1987;32:115-117.[Web of Science][Medline] [Order article via Infotrieve]
• Luce MF Decision making as coping. Health Psychol. 2005;24(suppl):S23-S28.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Maisiak R., Austin J., Heck L. Health outcomes of two telephone interventions for patients with rheumatoid arthritis or osteoarthritis. Arthritis Rheum. 1996;39:1391-1399.[Web of Science][Medline] [Order article via Infotrieve]
• Bosworth HB Medication treatment adherence. In: Bosworth HB, Oddone EZ, Weinberger M, eds. Patient Treatment Adherence: Concepts, Interventions, and Measurement. Mahwah, NJ: Erlbaum; 2006:147-194.
• Cook PF Methods for assessing medication compliance. http://www.scriptassistllc.com/vendor/research. Accessed June 8, 2006.
• Fletcher SW, Pappius EM, Harper SJ Measurement of medication compliance in a clinical setting: comparison of three methods in patients prescribed digoxin. Arch Intern Med. 1979;139:635-638.[Abstract/Free Full Text]
• Levine AJ, Hinkin CH, Marion S., et al. Adherence to anti-retroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Health Psychol. 2006;25:329-355.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Anstrom KJ, Weinfurt KP, Allen AS Estimating causal effects in randomized studies with imperfect adherence: conceptual and statistical foundations. In: Bosworth HB, Oddone EZ, Weinberger M, eds. Patient Treatment Adherence: Concepts, Interventions, and Measurement. Mahwah, NJ: Erlbaum; 2006:453-474.
• McHugh ML Calculation and utility of a one-way chi-square in nursing practice. J Spec Pediatr Nurs. 2005;10:201-203.
• Little RJ, Yau Lhy. Statistical techniques for analyzing data from prevention trials: treatment of no-shows using Rubin's causal model. Psychol Methods. 1998;3:147-159.[CrossRef][Web of Science]
• Ballinger M. Compliance dwindles as drug costs escalate. Managed Healthc Exec. 2002;January:9-10.
• Kaiser Family Foundation. Survey finds four in 10 seniors do not take medications as prescribed. http://www.kff.org/medicare/med041905nr.cfm. Accessed August 28, 2006.

American Journal of Medical Quality, Vol. 22, No. 6, 445-456 (2007)
DOI: 10.1177/1062860607307990


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (2) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cook, P. F. Articles by McCabe, M. M. Search for Related Content PubMed PubMed Citation Articles by Cook, P. F. Articles by McCabe, M. M. Pubmed/NCBI databases Medline Plus Health Information Osteoporosis Social Bookmarking                         What's this?